First, the combination of Industry-University-Research and the continuous innovation system construction.
The rapid and sustainable development of Hualan biology depends on strong scientific research investment. The company will spend 5- 10% of its annual sales revenue on the research and development of new products. The company has "one station, two centers and two joint laboratories" [postdoctoral research center, Henan Biomedical (Preparation) Engineering Technology Research Center and National Enterprise Technology Center, protein Engineering Separation and Purification Joint Laboratory jointly established with Chinese Academy of Sciences, and R&D Laboratory established in cooperation with Shanghai Pasteur Institute of Chinese Academy of Sciences], which provides a powerful scientific research and product incubation platform for the company in the research and development and production of biological products and vaccines.
Two, innovation and reform, comprehensive utilization, to maintain the leading blood products industry.
At present, the company's annual production capacity of blood products is nearly 3,000 tons, and its production scale, varieties, specifications, market share and coverage rate rank first in China and even in Asia. A bag of plasma can separate 15 products, including 1 1 products with nearly 40 specifications, mainly including human albumin, intravenous human immunoglobulin and factor VIII. In 2004, the production technology of freeze-dried human fibrin glue obtained the national patent number, which filled the domestic blank. Except for human albumin, which is pasteurized, all products are inactivated by double viruses with different inactivation mechanisms, reaching the international advanced level.
Three, a high starting point, high standards, international standards of modern vaccine production and storage base.
In 2005, the company strategically entered the field of vaccines and established Hualan Biological Vaccine Co., Ltd. Through independent innovation and research, Hualan Biological Company has more than ten kinds of products such as influenza virus split vaccine, influenza A vaccine H 1N 1, tetravalent epidemic cerebrospinal meningitis vaccine, hepatitis B vaccine, Japanese encephalitis vaccine and rabies vaccine for human use.
Fourthly, the spirit of Hualan people is formed, developed and continued in the process of development.
The sustained and rapid development of Hualan Bio is the result of the joint efforts of all Hualan employees. For more than ten years, the company has been focusing on the field of biopharmaceuticals, concentrating on development, striving for innovation, constantly making Hualan brand bigger and stronger, and striving to build a national brand. Constantly overcome all kinds of difficulties in development, overcome development bottlenecks, adhere to scientific development, and form the enterprise spirit of "unity and pioneering, dedication and forge ahead" in realizing leap-forward development, forging a group of production R&D and management teams that are particularly hard-working, skilled in business technology, high in work efficiency and good in unity and cooperation. Adhering to the quality policy of "no limit to the safety of blood products" and the business purpose of "ensuring credibility by quality and safety", all Hualan people have worked hard, made pioneering efforts, constantly climbed higher peaks in the biomedical field, strived to protect public health and national health and safety, and wrote a new chapter of "All for human health" in Hualan Bio.
For more information, please visit official website:/
Legal Representative: Ankang
Date of establishment: 1992-03-30
Registered capital: 930,087,680 yuan.
Location: Henan Province
Unified social credit code: 914100061491414g.
Business status: surviving (in business, in business, on record)
Industry: manufacturing industry
Company type: joint-stock company (Taiwan, Hong Kong, Macao and domestic joint venture listing)
Chinese name: Hualan Bioengineering Co., Ltd.
Staff size: 500-999 people.
Enterprise Address:No. 1 Hualan Avenue, Xinxiang
Scope: Production and sales of self-produced biological products and blood products.